BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 30161147)

  • 1. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis.
    Schnippel K; Mongwenyana C; Long LC; Larson BA
    BMC Infect Dis; 2015 Feb; 15():46. PubMed ID: 25656597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Option B+ Program for the Prevention of Vertical Transmission of HIV: A Case Study in Johannesburg, South Africa.
    Bisnauth MA; Coovadia A; Mbuagbaw L; Wilson MG; Birch S
    Front Public Health; 2020; 8():533534. PubMed ID: 33194942
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
    Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cluster randomized controlled trial of lay health worker support for prevention of mother to child transmission of HIV (PMTCT) in South Africa.
    Peltzer K; Weiss SM; Soni M; Lee TK; Rodriguez VJ; Cook R; Alcaide ML; Setswe G; Jones DL
    AIDS Res Ther; 2017 Dec; 14(1):61. PubMed ID: 29248014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.
    Chetty T; Thorne C; Tanser F; Bärnighausen T; Coutsoudis A
    BMJ Open; 2016 Oct; 6(10):e012088. PubMed ID: 27798004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study.
    DiCarlo AL; Gachuhi AB; Mthethwa-Hleta S; Shongwe S; Hlophe T; Peters ZJ; Zerbe A; Myer L; Langwenya N; Okello V; Sahabo R; Nuwagaba-Biribonwoha H; Abrams EJ
    BMC Health Serv Res; 2019 Apr; 19(1):210. PubMed ID: 30940149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress Toward Eliminating Mother to Child Transmission of HIV in Kenya: Review of Treatment Guidelines Uptake and Pediatric Transmission Between 2013 and 2016-A Follow Up.
    Pricilla RA; Brown M; Wexler C; Maloba M; Gautney BJ; Finocchario-Kessler S
    Matern Child Health J; 2018 Dec; 22(12):1685-1692. PubMed ID: 30047080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape.
    Pellowski J; Wedderburn C; Stadler JAM; Barnett W; Stein D; Myer L; Zar HJ
    BMJ Open; 2019 Dec; 9(12):e033259. PubMed ID: 31843848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Mother-to-Child Transmission of HIV in Option B+ Era: Uptake and Adherence During Pregnancy in Western Uganda.
    Schnack A; Rempis E; Decker S; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
    AIDS Patient Care STDS; 2016 Mar; 30(3):110-8. PubMed ID: 27308804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of non-adherence to anti-retroviral therapy, the associated factors and infant outcomes among HIV-positive pregnant women: a prospective cohort study in Lesotho.
    Kadima N; Baldeh T; Thin K; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2018; 30():239. PubMed ID: 30574258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
    Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
    Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.
    Rawizza HE; Chang CA; Chaplin B; Ahmed IA; Meloni ST; Oyebode T; Banigbe B; Sagay AS; Adewole IF; Okonkwo P; Kanki PJ;
    Curr HIV Res; 2015; 13(3):201-9. PubMed ID: 25986371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.